Clinical characteristics and SAP scintigraphic findings in 10 patients with AGel amyloidosis

Amyloid

Volumn 21, Issue 4, 2014, Pages 276-281

  Rowczenio, Dorota ^a   Tennent, Glenys A ^a   Gilbertson, Janet ^a   Lachmann, Helen J ^a   Hutt, David F ^a   Bybee, Alison ^a   Hawkins, Philip N ^a   Gillmore, Julian D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

123I SAP scintigraphy; Corneal lattice dystrophy; Cranial neuropathy; Hereditary gelsolin (AGel) amyloidosis; Renal amyloid

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; FIBRINOGEN; GELSOLIN; IODINE 123; LYSOZYME; PREALBUMIN; SERUM AMYLOID P;

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CORNEA DYSTROPHY; CRANIAL NEUROPATHY; CUTIS LAXA; FAMILIAL AMYLOIDOSIS; FEMALE; GAMMA CAMERA; GENE MUTATION; HEART AMYLOIDOSIS; HUMAN; KIDNEY FUNCTION; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL NEUROPATHY; PHENOTYPE; PROTEINURIA; SCINTILLATION CAMERA; SJOEGREN SYNDROME; UNITED KINGDOM; WHOLE BODY SCINTISCANNING; AMYLOIDOSIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; TANDEM MASS SPECTROMETRY;

AGED; AMYLOIDOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; TANDEM MASS SPECTROMETRY;

EID: 84908510458     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2014.973105     Document Type: Article

References (42)

1. Saraiva MJM, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloid polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984;74:104-19.
2. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996;3:44-56.
3. Nichols WC, Dwulet FE, Liepnieks J, Benson MD. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 1988;156:762-8.
4. Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol 2011;179:1978-87.
5. Benson MD, Liepnieks JJ, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B, Kluve-Beckerman B. A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipo-protein AII gene. Genomics 2001;72:272-7.
6. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993;362:553-7.
7. Gillmore JD, Booth DR, Madhoo S, Pepys MB, Hawkins PN. Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol Dial Transplant 1999;14:2639-44.
8. Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen a-chain. Nat Genet 1993;3:252-5.
9. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of g-trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986; 83:2974-8.
10. Ghiso J, Haltia M, Prelli F, Novello J, Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990; 272:827-30.
11. Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, et al. Hereditary systemic amyloidosis due to Asp76Asn variant beta2-microglobulin. N Engl J Med 2012;366: 2276-83.
12. Maury CPJ, Alli K, Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett 1990;260:85-7.
13. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990;172:1865-7.
14. Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993;33:57-62.
15. Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, Onishi A, et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996; 103:1106-10.
16. de la Chapelle A, Kere J, Sack Jr GH, Tolvanen R, Maury CPJ. Familial amyloidosis, Finnish type: G654-a mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992;13:898-901.
17. Purcell Jr JJ, Rodrigues M, Chishti MI, Riner RN, Dooley JM. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 1983;90: 1512-17.
18. Stewart HS, Parveen R, Ridgway AE, Bonshek R, Black GC, et al. Late onset lattice corneal dystrophy with systemic familial amyl-oidosis, amyloidosis V, in an English family. Br J Ophthalmol 2000; 84:390-4.
19. Huerva V, Velasco A, Sanchez MC, Mateo AJ, Matias-Guiu X. Lattice corneal dystrophy type II: clinical, pathologic, and molecular study in a Spanish family. Eur J Ophthalmol 2007;17: 424-9.
20. Chastan N, Baert-Desurmont S, Saugier-Veber P, Derumeaux G, Cabot A, Frebourg T, Hannequin D. Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p.Asp187Tyr mutation in the GSN gene. Muscle Nerve 2006;33: 113-19.
21. Luttmann RJ, Teismann I, Husstedt IW, Ringelstein EB, Kuhlenbaumer G. Hereditary amyloidosis of the Finnish type in a German family: clinical and electrophysiological presentation. Muscle Nerve 2010;41:679-84.
22. Maury CP, Liljestrom M, Boysen G, Tornroth T, de la Chapelle A, Nurmiaho-Lassila EL. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol 2000;53: 95-9.
23. Conceicao I, Sales-Luis ML, De Carvalho M, Evangelista T, Fernandes R, Paunio T, Kangas H, et al. Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological studies. Muscle Nerve 2003;28:715-21.
24. Solari HP, Ventura MP, Antecka E, Belfort Jr R, Burnier Jr MN. Danish type gelsolin-related amyloidosis in a Brazilian family: case reports. Arq Bras Oftalmol 2011;74:286-8.
25. Ardalan MR, Shoja MM, Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant 2007;22: 272-5.
26. Maury CPJ. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 1991;87:1195-9.
27. de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury CPJ, Kere J. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992;2:157-60.
28. Sethi S, Theis JD, Quint P, Maierhofer W, Kurtin PJ, Dogan A, Highsmith Jr EW,. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis 2013;61: 161-6.
29. Efebera YA, Sturm A, Baack EC, Hofmeister CC, Satoskar A, Nadasdy T, Nadasdy G, et al. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid 2014;21:110-12.
30. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid: Int J Exp Clin Invest 1998;5:55-66.
31. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, Mbewu A, Miller JP, Durrington P, Humphries S. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterol-aemia. Atherosclerosis 1991;89:137-41.
32. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997;385:787-93.
33. Thr-Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995;91:962-7.
34. Tennent GA. Isolation and characterization of amyloid fibrils from tissue. In: Wetzel R, ed. Methods in enzymology: amyloid, prions and other protein aggregates, vol. 309. San Diego, CA: Academic Press Ltd; 1999:26-47.
35. Rodriguez FJ, Gamez JD, Vrana JA, Theis JD, Giannini C, Scheithauer BW, Parisi JE, et al. Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Lab Invest 2008;88:1024-37.
36. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
37. 123I-labeled serum amyloid P component. N Engl J Med 1990; 323:508-13.
38. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986; 323:455-8.
39. Yin HL, Kwiatkowski DJ, Mole JE, Cole FS. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984;259:5271-6.
40. Kazmirski SL, Howard MJ, Isaacson RL, Fersht AR. Elucidating the mechanism of familial amyloidosis-Finnish type: NMR studies of human gelsolin domain 2. Proc Natl Acad Sci USA 2000; 97:10706-11.
41. Yamanaka S, Miyazaki Y, Kasai K, Ikeda S, Kiuru-Enari S, Hosoya T. Hereditary renal amyloidosis caused by a heterozygous G654A gelsolin mutation: a report of two cases. Clin Kidney J 2013;6: 189-93.
42. Maury CP, Kere J, Tolvanen R, de la Chapelle A. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 1992;13:902-3.